ADHD Medication: A Conversation with Paediatrician Tommy Tran
In the world of paediatric medicine, addressing Attention Deficit Hyperactivity Disorder (ADHD) is a common challenge. To shed light on this issue, we sit down with Dr. Tommy Tran, an experienced paediatrician with a special focus on ADHD, for an insightful conversation. Dr. Tran shares his extensive knowledge about ADHD medication and its impact on children, addressing concerns and highlighting the importance of a holistic approach to treatment.
Dr. Tran's Background:
Dr. Tommy Tran has been a consultant paediatrician for over 11 years, dedicating a total of 18 years to the field of paediatrics. Currently serving as the clinical director at Peds and Epod, a private practice, Dr. Tran has encountered and assisted numerous families dealing with ADHD. In this conversation, he shares his expertise on ADHD medication, providing valuable insights for parents seeking guidance.
The Effectiveness of Medication for ADHD:
The discussion kicks off with an exploration of the effectiveness of medication in managing ADHD symptoms. Dr. Tran emphasises that for children above the age of six, medication is often recommended as a first-line option. He explains that medication primarily addresses core symptoms such as attention, hyperactivity, and impulse control. The goal is to improve learning, behaviour, and overall organisation in children.
Types of ADHD Medications:
Delving deeper, Dr. Tran categorises ADHD medications into stimulants and non-stimulants. Stimulants like Ritalin, Dexamphetamine, and Vyvanse are commonly prescribed, while non-stimulants such as Intuniv or Strattera may be considered if stimulants are not well-tolerated. He provides a brief overview of each type, helping parents understand the options available for their child.
Challenges and Side Effects:
Addressing potential challenges, Dr. Tran outlines common side effects of stimulant medications, including appetite suppression, sleep difficulties, and irritability. He discusses situations where stimulants might not be suitable, such as in children with anxiety issues. Additionally, he shares strategies for managing side effects and highlights the importance of avoiding harm in the treatment process.
Parental Concerns and Communication:
Recognizing that starting a child on medication can be a significant decision for parents, Dr. Tran acknowledges common concerns, particularly regarding potential personality changes. He reassures parents that finding the right balance in dosage is crucial, emphasising the ongoing and collaborative nature of the conversation between healthcare professionals and families.
Long-Term Impacts and Future Considerations:
Looking towards the future, Dr. Tran addresses parents' worries about the long-term impacts of ADHD medication. He discusses concerns related to drug use and addiction, highlighting the importance of ongoing monitoring and reassurance. The conversation touches on the evolving needs of children as they grow, emphasising the individualised nature of ADHD management.
As the conversation concludes, Dr. Tran and the psychologist reflect on the multifaceted aspects of ADHD management. From addressing core symptoms to considering long-term implications, the dialogue provides valuable insights for parents navigating the journey of ADHD treatment. This conversation sets the stage for future discussions on supporting families through various aspects of ADHD management, including school interventions and parenting strategies.
